CHB Investment Group LLC raised its holdings in The Allstate Corporation (NYSE:ALL - Free Report) by 7.9% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 17,092 shares of the insurance provider's stock after buying an additional 1,249 shares during the quarter. CHB Investment Group LLC's holdings in Allstate were worth $3,441,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Arlington Trust Co LLC increased its holdings in Allstate by 261.8% in the 2nd quarter. Arlington Trust Co LLC now owns 123 shares of the insurance provider's stock valued at $25,000 after buying an additional 89 shares during the period. Hughes Financial Services LLC bought a new stake in Allstate in the 1st quarter valued at $28,000. Meeder Asset Management Inc. increased its holdings in Allstate by 113.8% in the 1st quarter. Meeder Asset Management Inc. now owns 186 shares of the insurance provider's stock valued at $39,000 after buying an additional 99 shares during the period. McClarren Financial Advisors Inc. bought a new stake in Allstate in the 1st quarter valued at $43,000. Finally, Mattson Financial Services LLC bought a new stake in Allstate in the 4th quarter valued at $44,000. Institutional investors own 76.47% of the company's stock.
Allstate Stock Up 0.5%
Shares of NYSE:ALL opened at $207.56 on Wednesday. The Allstate Corporation has a 12 month low of $176.00 and a 12 month high of $214.76. The company's 50-day moving average price is $202.14 and its two-hundred day moving average price is $200.61. The company has a quick ratio of 0.43, a current ratio of 0.43 and a debt-to-equity ratio of 0.37. The firm has a market cap of $54.69 billion, a P/E ratio of 9.76, a P/E/G ratio of 0.81 and a beta of 0.37.
Allstate (NYSE:ALL - Get Free Report) last issued its quarterly earnings data on Wednesday, July 30th. The insurance provider reported $5.94 EPS for the quarter, topping analysts' consensus estimates of $3.20 by $2.74. Allstate had a net margin of 8.79% and a return on equity of 28.74%. The firm had revenue of $15.05 billion for the quarter, compared to analyst estimates of $16.59 billion. During the same quarter in the prior year, the firm earned $1.61 EPS. The company's revenue was up 5.8% on a year-over-year basis. As a group, research analysts forecast that The Allstate Corporation will post 18.74 EPS for the current fiscal year.
Allstate Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 1st. Shareholders of record on Friday, August 29th will be issued a dividend of $1.00 per share. The ex-dividend date of this dividend is Friday, August 29th. This represents a $4.00 dividend on an annualized basis and a yield of 1.9%. Allstate's dividend payout ratio is currently 18.81%.
Wall Street Analyst Weigh In
Several research firms have recently weighed in on ALL. Morgan Stanley upped their target price on shares of Allstate from $235.00 to $245.00 and gave the stock an "overweight" rating in a report on Friday, August 1st. UBS Group upped their target price on shares of Allstate from $230.00 to $235.00 and gave the stock a "buy" rating in a report on Wednesday, July 9th. Wall Street Zen raised shares of Allstate from a "hold" rating to a "buy" rating in a report on Tuesday, August 5th. BMO Capital Markets upped their target price on shares of Allstate from $230.00 to $235.00 and gave the stock an "outperform" rating in a report on Wednesday, August 20th. Finally, Keefe, Bruyette & Woods upped their target price on shares of Allstate from $237.00 to $246.00 and gave the stock an "outperform" rating in a report on Wednesday, August 6th. Two analysts have rated the stock with a Strong Buy rating, twelve have issued a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Allstate has an average rating of "Moderate Buy" and a consensus target price of $231.47.
View Our Latest Stock Analysis on Allstate
Allstate Profile
(
Free Report)
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
See Also
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Corporation (NYSE:ALL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Allstate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.
While Allstate currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.